// App-Quantinova.ai

2910 : Molecular Subtypes with Distinct Clinical Phenotypes and Actionable Targets in Adult B Cell Precursor ALL Treatment According to GMALL Protocols

Researchers

Presenter

  • Lorenz Bastian

Principal Investigators

  • Sonja Hnzelmann

  • Martin Neumann

  • Alina Hartmann

  • Thomas Burmeister

  • Stefan Schwartz

  • Walter Fiedler

  • Mustafa Kondakci

  • Andreas Viardot

  • Folker Schneller

  • Christoph Faul

  • Max S. Topp

  • Sren Franzenburg

  • Andre Franke

  • Heiko Trautmann

  • Nicola Goekbuget

  • Monika Brggemann

  • Claudia D Baldus

Medical Centers

  • Medical Department II of Hematology and Oncology, University Hospitals of Schleswig Holstein, Campus Kiel, Germany.

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

  • Department of Hematology and Oncology, Charite Campus Benjamin Franklin and Mitte, Berlin, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

  • University of Tubingen, Tubingen, Germany

  • Comprehensive Cancer Center Mainfranken and Department of Internal Medicine II, Division of Hematology and Medical Oncology, Wuerzburg, Germany

  • Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany

  • University Hospital, Department of Medicine II, Hematology/Oncology, Head of Study Center Depart of Medicine II, Hematology/Oncology Goethe University Hospital, Frankfurt, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • B-cell lymphoma 2

  • CCAAT enhancer binding protein alpha

  • Platelet Derived Growth Factor Receptor Beta

  • cMYC

  • Colony stimulating factor 1 receptor

  • ETV6-RUNX1

  • Histone-lysine N-methyltransferase 2A

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved